Lexeo Therapeutics to Host Virtual Event on PKP2-Associated Arrhythmogenic Cardiomyopathy

Lexeo Therapeutics will host a virtual event at the 22nd Global Cardiovascular Clinical Trialists Forum on December 9th at 3 PM ET. The session will feature a discussion with Dr. Victoria Parikh, an Associate Professor of Cardiovascular Medicine at Stanford University, about managing PKP2-associated arrhythmogenic cardiomyopathy. The event is open to analysts and investors, and a replay will be available on Lexeo's website.